tiprankstipranks
Candel Therapeutics (CADL)
NASDAQ:CADL
US Market

Candel Therapeutics (CADL) Income Statement

Compare
293 Followers

Candel Therapeutics Income Statement

Last quarter (Q3 2024), Candel Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Candel Therapeutics's net income was $-10.65M. See Candel Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 125.00K$ 125.00K$ 125.00K$ 125.00K
Gross Profit
$ -23.98M$ -862.00K$ -107.00K$ 125.00K$ -6.48M
Operating Expenses
$ 14.41M$ 34.80M$ 24.77M$ 13.31M$ 8.59M
Depreciation and Amortization
$ 960.00K$ 987.00K$ 232.00K$ 91.00K$ 43.00K
EBITDA
$ -37.43M$ -17.32M$ -25.49M$ -13.72M$ -8.20M
Operating Income
$ -38.39M$ -34.72M$ -25.73M$ -13.81M$ -9.04M
Other Income/Expenses
$ 452.00K$ 15.93M$ -10.40M$ -3.87M$ 797.00K
Pretax Income
$ -37.94M$ -18.79M$ -36.12M$ -17.68M$ -8.24M
Net Income
$ -37.94M$ -2.87M$ -36.18M$ -22.17M$ -8.01M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.31$ -0.10$ -1.26$ -0.76$ -0.27
Diluted EPS
$ -1.31$ -0.10$ -1.26$ -0.76$ -0.27
Weighted Average Shares Outstanding
28.94M 28.82M 28.69M 29.15M 29.15M
Weighted Average Shares Outstanding (Diluted)
28.94M 28.82M 28.69M 29.15M 29.15M
Currency in USD

Candel Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis